About AstraZeneca UAE
AstraZeneca is a British-Swedish biopharmaceutical company headquartered in Cambridge, England. It operates in the UAE and the Gulf, providing medicines across several therapeutic areas.
Its main focus areas are oncology, cardiovascular, renal and metabolic diseases, respiratory conditions such as asthma and COPD, and rare diseases through its Alexion business.
Diabetes and related heart and kidney conditions are major health challenges in the UAE, making medicines in these areas particularly relevant.
AstraZeneca was among the companies that developed a COVID-19 vaccine, in partnership with the University of Oxford, during the pandemic.
In the Gulf, the company works with health authorities and hospitals on access to medicines, disease awareness and medical education, and has taken part in partnerships aimed at improving early diagnosis.
Global pharmaceutical companies often use their regional offices in the UAE to serve markets across the Middle East and Africa.
AstraZeneca is a British-Swedish company rather than a UAE startup, and Startups UAE lists its UAE operations among the country's pharmaceutical companies.
Its main focus areas are oncology, cardiovascular, renal and metabolic diseases, respiratory conditions such as asthma and COPD, and rare diseases through its Alexion business.
Diabetes and related heart and kidney conditions are major health challenges in the UAE, making medicines in these areas particularly relevant.
AstraZeneca was among the companies that developed a COVID-19 vaccine, in partnership with the University of Oxford, during the pandemic.
In the Gulf, the company works with health authorities and hospitals on access to medicines, disease awareness and medical education, and has taken part in partnerships aimed at improving early diagnosis.
Global pharmaceutical companies often use their regional offices in the UAE to serve markets across the Middle East and Africa.
AstraZeneca is a British-Swedish company rather than a UAE startup, and Startups UAE lists its UAE operations among the country's pharmaceutical companies.